Skip to main content
. 2017 Feb 24;7:43489. doi: 10.1038/srep43489

Table 1. Substrate specificity of the recombinant SALDan.

Substrates App Km (μM) App Vmax (U/mg) App kcat (s−1) App kcat/Km (s−1 μM−1) App Ki (μM)
Salicylaldehyde 3.8 ± 0.5 49.5 ± 4.5 123.6 ± 13.6 32.5 ± 4.2 378.7 ± 45.2
Benzaldehyde 2.3 ± 0.3 22.6 ± 3.8 56.1 ± 10.5 24.2 ± 2.9 562.6 ± 87.6
2-Chlorobenzaldehyde 3.2 ± 0.3 45.6 ± 6.2 114.2 ± 17.2 35.7 ± 4.5 356.4 ± 40.1
3-Chlorobenzaldehyde 4.8 ± 0.7 56.8 ± 7.2 142.1 ± 20.5 29.6 ± 3.5 123.9 ± 20.1
4-Chlorobenzaldehyde 5.5 ± 1.1 74.2 ± 5.8 185.5 ± 16.1 33.7 ± 2.8 132.1 ± 18.9
4-Nitrobenzaldehyde 6.5 ± 0.9 32.3 ± 4.6 80.2 ± 14.5 12.3 ± 2.0 265.7 ± 35.8
2-Naphthaldehyde 3.4 ± 0.5 61.4 ± 5.1 153.1 ± 14.4 45.0 ± 4.4 248.5 ± 22.5
Formaldehyde 12360 ± 1820.0 3.3 ± 0.7 8.6 ± 2.2 7.0E−04 ± 8.4E−03
Butyraldehyde 3200 ± 235.0 5.9 ± 1.0 14.3 ± 2.8 4.5E−03 ± 5.7E−02
Glutaraldehyde 560 ± 46.0 11.6 ± 1.2 29.6 ± 3.7 5.3E−02 ± 4.9E−01

“—” means not observed.